Intron A



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 41.6%
Malignant Melanoma 27.4%
Drug Use For Unknown Indication 6.5%
Product Used For Unknown Indication 5.8%
Metastatic Renal Cell Carcinoma 3.3%
Renal Cell Carcinoma Stage Unspecified 2.7%
Multiple Myeloma 2.0%
Renal Cancer Metastatic 1.7%
Metastatic Malignant Melanoma 1.4%
Renal Cell Carcinoma 1.1%
Haemangioma 1.0%
Malignant Melanoma Stage Iii 1.0%
Hepatic Cirrhosis 0.8%
Hepatitis B 0.6%
Small Intestine Carcinoma 0.6%
Chronic Hepatitis 0.5%
Hiv Infection 0.5%
Mycosis Fungoides 0.5%
Renal Cancer 0.5%
Allergic Granulomatous Angiitis 0.4%
Weight Decreased 19.0%
Vomiting 12.1%
White Blood Cell Count Decreased 12.1%
Neutropenia 6.5%
Death 5.6%
Neutrophil Count Decreased 4.4%
Pyrexia 4.0%
Urinary Incontinence 3.6%
Cognitive Disorder 3.2%
Convulsion 3.2%
Myocardial Infarction 3.2%
Asthenia 2.8%
Nausea 2.8%
Platelet Count Decreased 2.8%
Cellulitis 2.4%
Retinal Detachment 2.4%
Thrombocytopenia 2.4%
Tremor 2.4%
Vision Blurred 2.4%
Visual Acuity Reduced 2.4%
Secondary
Hepatitis C 43.4%
Hypertension 6.8%
B-cell Lymphoma 5.8%
Drug Use For Unknown Indication 5.6%
Malignant Melanoma 5.2%
Metastatic Renal Cell Carcinoma 4.8%
Renal Cell Carcinoma Stage Unspecified 3.6%
Renal Cell Carcinoma 3.3%
Hiv Infection 2.4%
Asthma 2.1%
Chronic Myeloid Leukaemia 2.1%
Gout 1.9%
Hepatic Neoplasm Malignant 1.9%
Acquired Immunodeficiency Syndrome 1.7%
Constipation 1.7%
Multiple Myeloma 1.7%
Hepatitis C Virus Test Positive 1.6%
Product Used For Unknown Indication 1.6%
Blood Pressure 1.5%
Insomnia 1.3%
Pyrexia 15.7%
Vomiting 10.5%
Pancreatitis Acute 8.7%
Weight Decreased 7.6%
Finger Hypoplasia 6.4%
White Blood Cell Count Decreased 5.2%
Cerebral Infarction 4.7%
Myelodysplastic Syndrome 4.7%
Platelet Count Decreased 4.1%
Rash 4.1%
Thrombocytopenia 4.1%
Death 3.5%
Salmonella Sepsis 3.5%
Pancytopenia 2.9%
Type 1 Diabetes Mellitus 2.9%
Drug Ineffective 2.3%
Hepatic Neoplasm Malignant 2.3%
Lymph Node Tuberculosis 2.3%
Malaise 2.3%
Polymyositis 2.3%
Concomitant
Hiv Infection 12.4%
Hepatitis C 11.8%
Multiple Myeloma 10.4%
Diabetes Mellitus 8.6%
Pain 8.4%
Renal Cell Carcinoma 5.2%
Hypertension 4.9%
Metastases To Bone 4.9%
Oral Infection 4.3%
Constipation 3.7%
Metastatic Renal Cell Carcinoma 3.2%
Nuclear Magnetic Resonance Imaging 3.2%
Product Used For Unknown Indication 3.2%
Antiviral Prophylaxis 2.9%
Hepatitis B 2.9%
Depression 2.3%
Premedication 2.3%
Prophylaxis 2.0%
Insomnia 1.7%
Liver Transplant Rejection 1.7%
Wound Drainage 11.2%
Hepatic Fibrosis 6.7%
Nephrogenic Systemic Fibrosis 6.7%
Osteonecrosis 6.7%
Platelet Count Decreased 6.7%
Tooth Extraction 6.7%
Vomiting 6.7%
Rash 5.6%
Hepatic Neoplasm Malignant 4.5%
Liver Disorder 4.5%
Hepatic Failure 3.4%
Hepatitis C 3.4%
Neoplasm Malignant 3.4%
Palmar-plantar Erythrodysaesthesia Syndrome 3.4%
Peritonitis 3.4%
Pyrexia 3.4%
Rash Generalised 3.4%
Rheumatoid Arthritis 3.4%
Skin Discolouration 3.4%
Weight Decreased 3.4%